JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Edwards Lifesciences Corp

Closed

SectorHealthcare

79.94 5.8

Overview

Share price change

24h

Current

Min

78.92

Max

79.99

Key metrics

By Trading Economics

Income

-29M

356M

Sales

27M

1.4B

P/E

Sector Avg

31.636

38.156

EPS

0.64

Profit margin

25.228

Employees

15,800

EBITDA

-50M

434M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+10.25% upside

Dividends

By Dow Jones

Next Earnings

23 Oct 2025

Market Stats

By TradingEconomics

Market Cap

150M

45B

Previous open

74.14

Previous close

79.94

News Sentiment

By Acuity

26%

74%

42 / 375 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Edwards Lifesciences Corp Chart

Past performance is not a reliable indicator of future results.

Related News

25 Oct 2024, 09:10 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 Oct 2024, 08:35 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3 Sept 2024, 20:38 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 Sept 2024, 20:37 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 Sept 2024, 20:36 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

Peer Comparison

Price change

Edwards Lifesciences Corp Forecast

Price Target

By TipRanks

10.25% upside

12 Months Forecast

Average 88.2 USD  10.25%

High 101 USD

Low 79 USD

Based on 23 Wall Street analysts offering 12 month price targets forEdwards Lifesciences Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

23 ratings

13

Buy

10

Hold

0

Sell

Technical Score

By Trading Central

74.52 / 75.54Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

42 / 375 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.